- * 프린트는 Chrome에 최적화 되어있습니다. print
- Drug development for autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus)
- SARS-CoV-2 drug development
- Ongoing funded projects: NRF SRC (Cellular response to metabolic stress research center), UNIST collaboration project (AI-based development of Covid-19 drugs), NRF Individual Project (TonEBP in T cell-mediated pathogenesis of systemic lupus erythematosus and TonEBP targeting therapeutics)
Major research field
Autoimmune diseases, Drug development for Covid-19
Desired field of research
Research Keywords and Topics
- Metabolic diseases: diabetes, non-alcoholic steatohepatitis
- Autoimmune diseases: rheumatoid arthritis, systemic lupus erythematosus
- Covid-19 drug development
Research Publications
MOREKidney International. Macrophage TonEBP promotes systemic lupus erythematosus and renal injury via damage-induced signaling pathways. Yoo EJ, Oh KH, Piao H, Kang HJ, Jeong GW, Park H, Lee CJ, Ryu H, Yang SH, Kim MG, Kim DK, Park SH, Lim BJ, Lee SM, Park CY, Choi SY, Lee-Kwon W, Yang J, Kwon HM. 2023
Nature Reviews Nephrology. The evolving role of TonEBP as an immunometabolic stress protein. Choi SY, Lee-Kwon W, Kwon HM. 2020.
Gut. Tonicity-responsive enhancer binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis. Lee JH, Suh JH, Choi SY, Kang HJ, Lee HH, Ye BJ, Lee GR, Jung SW, Kim CJ, Lee-Kwon W, Park J, Myung K, Park NH, Kwon HM. 2019.
국가과학기술표준분류
- LA. 생명과학
- LA04. 면역학·생리학
- LA0499. 달리 분류되지 않는 면역학/생리학
국가기술지도분류
- 건강한 생명사회 지향
- 020400. 선도물질 최적화기술
녹색기술분류
- 녹색기술관련 과제 아님
6T분류
- BT 분야
- 기초/기반기술
- 020114. 생명현상 및 기능연구